âš¡India's First mRNA Vaccine Phase-I Clinical Trial Gets Nod
By IANS
The Central Drugs Standard Control Organisation (CDSCO), India's National Regulatory Authority, has approved Gennova Biopharmaceuticals Limited's work on the country's first mRNA-based COVID-19 vaccine for its clinical data of the phase-1 study.